Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Affinity and Avidity

Affinity and Avidity

Cross-reactivity

Cross-reactivity

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine.

Vaccine·2023

Same author

Bone density and strength from thoracic and lumbar CT scans both predict incident vertebral fractures independently of fracture location.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020

Same author

Mars Science Laboratory Observations of Chloride Salts in Gale Crater, Mars.

Geophysical research letters·2020

Same author

Neurophysiological evidence of impaired attention and working memory in untreated hematologic cancer patients.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019

Same author

Prediction of incident vertebral fracture using CT-based finite element analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018

Same author

Population-based study of age- and sex-related differences in muscle density and size in thoracic and lumbar spine: the Framingham study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018

Search research articles

Related Experiment Video

Updated: Jul 22, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Hypervariable epitope constructs as a means of accounting for epitope variability

D E Anderson¹, A Malley, E Benjamini

¹Department of Microbiology and Immunology, School of Medicine, University of California, Davis 95616.

|June 1, 1994

Summary

Developing synthetic peptide vaccines is challenging due to epitope variability. A novel hypervariable epitope construct (HEC) cocktail was created to address this, inducing antibodies that bind effectively to simian immunodeficiency virus (SIV).

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Related Experiment Videos

Last Updated: Jul 22, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

Area of Science:

Immunology and Virology
Vaccine Development

Background:

Epitope variability presents a significant hurdle in the creation of effective synthetic peptide vaccines.
The envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac142) contains a hypervariable epitope (aa 414-434) that exemplifies this challenge.

Purpose of the Study:

To develop a novel strategy to overcome epitope variability in vaccine design.
To create a peptide construct that accounts for in vivo epitope variations.
To assess the immunogenicity and binding capabilities of the developed construct.

Main Methods:

A cocktail of peptides, termed a hypervariable epitope construct (HEC), was synthesized.
The HEC represents all observed in vivo permutations of amino acid substitutions within the target epitope.
Antibody induction and binding affinity to native SIV and related epitope analogues were evaluated.

Main Results:

The HEC successfully induced antibodies with enhanced binding to native simian immunodeficiency virus (SIV).
The induced antibodies demonstrated broad immunoreactivity to related epitope analogues.
This approach effectively addresses epitope variability in vaccine candidate design.

Conclusions:

A hypervariable epitope construct (HEC) is a viable strategy to manage epitope variability in synthetic vaccines.
This method can lead to vaccines with broader efficacy against viral strains exhibiting epitope diversity.
Further research into HEC for vaccine development against simian immunodeficiency virus (SIV) and other pathogens is warranted.